Cancer is a heterogeneous disease whose treatment is complicated by differences in tumors’ innate molecular features, differences found even among tumors that are clinically and pathologically indistinguishable. Gene expression profiling — by qPCR, gene expression microarrays and other hybridization-based technologies, or RNA sequencing — provides one way of characterizing tumor heterogeneity. In...